Efficacy of Natalizumab in a French Cohort of Multiple Sclerosis Patients

被引：0
|
作者：
Outteryck, Olivier
Ongagna, Jean-Claude
Zephir, Helene
Fleury, M. -C.
Lacour, Arnaud
Blanc, Frederic
Vermersch, Patrick
de Seze, Jerome
机构：
来源：
NEUROLOGY | 2010年 / 74卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A550 / A551
页数：2
相关论文
共 50 条
  • [31] The immunogenicity of natalizumab in patients with multiple sclerosis.
    Giovannoni, Gavin
    O'Connor, Paul
    Havrdova, Eva
    Hutchinson, Michael
    Kappos, Ludwig
    Miller, David
    PhillipS, J. Theodore
    Polman, Chris
    Lublin, Fred
    Wajgt, Andrzej
    Lynn, Frances
    Panzara, Michael
    Sandrock, Alfred
    CLINICAL IMMUNOLOGY, 2006, 119 : S116 - S116
  • [32] The effect of Natalizumab on the retina of patients with Multiple Sclerosis
    Basili, Elisa
    Mauceri, Valentina Annamaria
    Ponzano, Marta
    Bovis, Francesca
    Miscioscia, Alessandro
    Zanotelli, Giovanni
    De Napoli, Federica
    Gaggiola, Marta
    Rinaldi, Francesca
    Perini, Paola
    Gallo, Paolo
    Puthenparampil, Marco
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 989 - 990
  • [33] Hypereosinophilia in patients with multiple sclerosis treated with natalizumab
    Abbas, M.
    Lalive, P. H.
    Chofflon, M.
    Simon, H. -U.
    Chizzolini, C.
    Ribi, C.
    NEUROLOGY, 2011, 77 (16) : 1561 - 1564
  • [34] Comparative effectiveness of natalizumab on cognition in multiple sclerosis: A cohort study
    Manouchehrinia, Ali
    Larsson, Hanna
    Karim, Mohammad Ehsanul
    Lycke, Jan
    Olsson, Tomas
    Kockum, Ingrid
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 (4-5) : 628 - 636
  • [35] Efficacy of Natalizumab in Multiple Sclerosis Patients with High Disease Activity: A Danish Nationwide Study
    Oturai, Annette Bang
    Koch-Henriksen, Nils
    Petersen, Thor
    Jensen, Poul Erik Hyldgaard
    Sellebjerg, Finn
    Sorensen, Per Soelberg
    NEUROLOGY, 2009, 72 (11) : A315 - A315
  • [36] Evaluating the efficacy and safety of transitioning patients with multiple sclerosis from natalizumab to ocrelizumab (OCTAVE)
    Smoot, Kyle
    Marginean, Horia
    Gervasi-Follmar, Tiffany
    Chen, Chiayi
    Repovic, Pavle
    Cohan, Stanley
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 (08) : 956 - 966
  • [37] NATALIZUMAB IN MULTIPLE SCLEROSIS
    Rio-Izquierdo, J.
    Montalban, X.
    REVISTA DE NEUROLOGIA, 2009, 49 (05) : 265 - 269
  • [38] Efficacy of natalizumab in multiple sclerosis patients with high disease activity: a Danish nationwide study
    Oturai, A. B.
    Koch-Henriksen, N.
    Petersen, T.
    Jensen, P. E. H.
    Sellebjerg, F.
    Sorensen, P. S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 (03) : 420 - 423
  • [39] Natalizumab in pediatric multiple sclerosis: results of a cohort of 55 cases
    Ghezzi, A.
    Pozzilli, C.
    Grimaldi, L. M. E.
    Moiola, L.
    Brescia-Morra, V.
    Lugaresi, A.
    Lus, G.
    Rinaldi, F.
    Rocca, M. A.
    Trojano, M.
    Bianchi, A.
    Comi, G.
    Filippi, M.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (08) : 1106 - 1112
  • [40] Natalizumab and multiple sclerosis
    Vellutini Pimentel, Maria Lucia
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2013, 71 (03) : 135 - 136
12345